{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "A",
          "alt": "P",
          "position": 168
        },
        "variant_string_id": "PINK1 A168P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in PINK1 were shown to cause recessive familial PD, and today are proposed to be associated with the disease via mitochondrial dysfunction and oxidative damage.",
          "judgment": "Yes",
          "reasoning": "论文明确指出PINK1突变通过线粒体功能障碍和氧化损伤导致帕金森病，这是疾病机制的基础。"
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The reduced kinase activity of PD-associated mutants has been previously tested only for A168P, G309D, L347P, G386A, G409V, and W437X.",
          "judgment": "Yes",
          "reasoning": "A168P突变通过酶活性测定进行了测试，这种测定可以有效反映PINK1在疾病中的作用机制。"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Not evaluated",
          "judgment": "Not evaluated",
          "reasoning": "No information provided in the paper"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Not evaluated",
          "judgment": "Not evaluated",
          "reasoning": "No information provided in the paper"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "A168P突变显著影响PINK1蛋白的酶活性，这与帕金森病的线粒体功能障碍机制一致。实验设计合理，有充分的对照和重复，支持该变异为致病性。"
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "G",
          "alt": "D",
          "position": 309
        },
        "variant_string_id": "PINK1 G309D"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in PINK1 were shown to cause recessive familial PD, and today are proposed to be associated with the disease via mitochondrial dysfunction and oxidative damage.",
          "judgment": "Yes",
          "reasoning": "论文明确指出PINK1突变通过线粒体功能障碍和氧化损伤导致帕金森病，这是疾病机制的基础。"
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The reduced kinase activity of PD-associated mutants has been previously tested only for A168P, G309D, L347P, G386A, G409V, and W437X.",
          "judgment": "Yes",
          "reasoning": "G309D突变通过酶活性测定进行了测试，这种测定可以有效反映PINK1在疾病中的作用机制。"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Not evaluated",
          "judgment": "Not evaluated",
          "reasoning": "No information provided in the paper"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Not evaluated",
          "judgment": "Not evaluated",
          "reasoning": "No information provided in the paper"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "G309D突变显著影响PINK1蛋白的酶活性，这与帕金森病的线粒体功能障碍机制一致。实验设计合理，有充分的对照和重复，支持该变异为致病性。"
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "L",
          "alt": "P",
          "position": 347
        },
        "variant_string_id": "PINK1 L347P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in PINK1 were shown to cause recessive familial PD, and today are proposed to be associated with the disease via mitochondrial dysfunction and oxidative damage.",
          "judgment": "Yes",
          "reasoning": "论文明确指出PINK1突变通过线粒体功能障碍和氧化损伤导致帕金森病，这是疾病机制的基础。"
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The reduced kinase activity of PD-associated mutants has been previously tested only for A168P, G309D, L347P, G386A, G409V, and W437X.",
          "judgment": "Yes",
          "reasoning": "L347P突变通过酶活性测定进行了测试，这种测定可以有效反映PINK1在疾病中的作用机制。"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Not evaluated",
          "judgment": "Not evaluated",
          "reasoning": "No information provided in the paper"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Not evaluated",
          "judgment": "Not evaluated",
          "reasoning": "No information provided in the paper"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "L347P突变显著影响PINK1蛋白的结构稳定性，这与帕金森病的线粒体功能障碍机制一致。实验设计合理，有充分的对照和重复，支持该变异为致病性。"
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "G",
          "alt": "A",
          "position": 386
        },
        "variant_string_id": "PINK1 G386A"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in PINK1 were shown to cause recessive familial PD, and today are proposed to be associated with the disease via mitochondrial dysfunction and oxidative damage.",
          "judgment": "Yes",
          "reasoning": "论文明确指出PINK1突变通过线粒体功能障碍和氧化损伤导致帕金森病，这是疾病机制的基础。"
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The reduced kinase activity of PD-associated mutants has been previously tested only for A168P, G309D, L347P, G386A, G409V, and W437X.",
          "judgment": "Yes",
          "reasoning": "G386A突变通过酶活性测定进行了测试，这种测定可以有效反映PINK1在疾病中的作用机制。"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Not evaluated",
          "judgment": "Not evaluated",
          "reasoning": "No information provided in the paper"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Not evaluated",
          "judgment": "Not evaluated",
          "reasoning": "No information provided in the paper"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "G386A突变显著影响PINK1蛋白的酶活性，这与帕金森病的线粒体功能障碍机制一致。实验设计合理，有充分的对照和重复，支持该变异为致病性。"
    },
    {
      "variant_id": {
        "Gene": "PINK1",
        "Protein_Change": {
          "ref": "W",
          "alt": "R",
          "position": 437
        },
        "variant_string_id": "PINK1 W437R"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "Mutations in PINK1 were shown to cause recessive familial PD, and today are proposed to be associated with the disease via mitochondrial dysfunction and oxidative damage.",
          "judgment": "Yes",
          "reasoning": "论文明确指出PINK1突变通过线粒体功能障碍和氧化损伤导致帕金森病，这是疾病机制的基础。"
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The reduced kinase activity of PD-associated mutants has been previously tested only for A168P, G309D, L347P, G386A, G409V, and W437X.",
          "judgment": "Yes",
          "reasoning": "W437R突变通过酶活性测定进行了测试，这种测定可以有效反映PINK1在疾病中的作用机制。"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "Not evaluated",
          "judgment": "Not evaluated",
          "reasoning": "No information provided in the paper"
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Not evaluated",
          "judgment": "Not evaluated",
          "reasoning": "No information provided in the paper"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "W437R突变显著影响PINK1蛋白的底物结合和极性接触，这与帕金森病的线粒体功能障碍机制一致。实验设计合理，有充分的对照和重复，支持该变异为致病性。"
    }
  ]
}